Abstract
Lipoprotein(a)(Lp(a)) was first discovered by Berg as a low-density lipoprotein like molecule in 1963. Much of the interest in the Lp(a) stems from several clinical studies that showed a highly significant association between elevated levels of the lipoprotein and susceptibilitiy to coronary artery disease(1). Compelling evidences accumulated in these 10 years indicate that Lp(a) is a major risk factor for atherosclerosis, coronary heart disease and cerebrovascular disease. Lp(a) is now believed to be independent from serum cholesterol and other risks. Lp(a) is composed of a lipid core, low-density lipoprotein containing an apoprotein B-100 subunit, and a unique lipoprotein ”apoprotein(a)(apo(a))”. The apo(a) subunit is linked by a disulfide bond to the apo B subunit.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dahlen G., Guyton JR., Atter M., Farmer JA., Kautz JA. and Gotto AM.Jr (1974) Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74; 758–765.
McLean, JW, Tomlinson, JE, Kuang, WJ, Eaton, EY, Fless, GM and Lawn, RM.(1987) cDNA sequence of human apoprotein (a) is homologous to plasminogen. Nature 300;132–137.
Morrisett JD, Guyton JR, Gaubatz JW, and Gotto AM. (1987) Lipoprotein(a):structure, metabolism and epidemiology. In: Gotto AM Jr, Ed. Plasma lipoproteins, Amsterdam: Elsevier Science, pp 129–152
Takada, A., Shizume, K., Ozawa, T., Takahashi, S. and Takada, T. (1986) Characterization of various antibodies against tissue plasminogen activator using highly sensitive enzyme immunoassay. Thromb Res. 42; 63–72.
Smith EB. and Cohran S. (1990) Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein II: preferential immobilization of lipoprotein(a)(Lp(a)). Atherosclerosis 84:173–181.
Gonzalez-Gronow M., Edelberg JM. and Pizzo SM. (1989) Further characterization of the cellular plasminogen binding sites:evidence that plasminogen 2 and lipoprotein(a) compete for the same site. Biochemistry 28:2374–2377.
Schernthaner, G., Kostner, GM., Dieplinger, R. and Mülhauser, I. (1983) Apolipoproteins(A-I, A-II, Lp(a) lipoprotein and lecithin: Cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 49:277–293.
Bruckert E., Davidoff P., Grimaldi A., Truffrt J., Giral P., Doumth R., Thervet F. and De Gennes J.L.(1990) Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA 263(1);35–36.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Japan
About this paper
Cite this paper
Taminato, T. et al. (1992). Lipoprotein (A) (LP(A)): Its Relevance to Diabetic Angiopathy. In: Takada, A., Budzynski, A.Z. (eds) Hemostasis and Circulation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66925-8_14
Download citation
DOI: https://doi.org/10.1007/978-4-431-66925-8_14
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70096-8
Online ISBN: 978-4-431-66925-8
eBook Packages: Springer Book Archive